FDA Approved: PIMECROLIMUS — Supplemental Application (Oceanside Pharmaceuticals)

View source ↗

Summary

FDA approved a supplemental application for pimecrolimus from Oceanside Pharmaceuticals, resulting in a modification to the drug's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Pimecrolimus (pimecrolimus)

Snippet

SUPPL AP for PIMECROLIMUS (PIMECROLIMUS)